‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
Swapna Mandal,Joseph Barnett,Simon E Brill,Jeremy S Brown,Emma K Denneny,Samanjit S Hare,Melissa Heightman,Toby E Hillman,Joseph Jacob,Hannah C Jarvis,Marc C I Lipman,Sindhu B Naidu,Arjun Nair,Joanna C Porter,Gillian S Tomlinson,John R Hurst,Aishah Ahmed,Asia Ahmed,Andrea Bangay,Izumi Barbor,Meg Barber,James Batty,Thea Buchan,Tom Burns,Alisha Chauhan,Roise Dudley,Ben Cooper,Mark Duncan,Nada Elsaid,Rebecca Evans,Samuel Flatau,Lydia Gabriel,James Goldring,Heather Groombridge,Liam Healy,Neel Jain,Afshan Khan,Camila Nagoda Niklewicz,Ezgi Ozcan,Preena Patel,Shivani Patel,Alexander Procter,Alice Ring,James Robertson,Portia Sagoe,Anita Saigal,George Seligmann,Runil Shah,Magali Taylor,Andrew Wendruff,Hannah Woodcock
DOI: https://doi.org/10.1136/thoraxjnl-2020-215818
2020-11-10
Thorax
Abstract:Large numbers of people are being discharged from hospital following COVID-19 without assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median 54 days post discharge, 53% reported persistent breathlessness, 34% cough and 69% fatigue. 14.6% had depression. In those discharged with elevated biomarkers, 30.1% and 9.5% had persistently elevated d-dimer and C reactive protein, respectively. 38% of chest radiographs remained abnormal with 9% deteriorating. Systematic follow-up after hospitalisation with COVID-19 identifies the trajectory of physical and psychological symptom burden, recovery of blood biomarkers and imaging which could be used to inform the need for rehabilitation and/or further investigation.
respiratory system